This NDC is on FDA's drug shortage list (posted Oct 12, 2022)
Product Information
DEXTROAMP-AMPHETAMIN 30 MG TAB is a generic product labeled by Sunrise Pharmaceutical Inc., priced at $0.3031 per EA under NDC 11534019601. Its NADAC has been published 311 times since Sep 9, 2020.
FDA first approved this application on Dec 28, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
DEXTROAMP-AMPHETAMIN 30 MG TAB
dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfateStrength
7.5; 7.5; 7.5; 7.5 mg/1; mg/1; mg/1; mg/1
Manufacturer
Sunrise Pharmaceutical Inc.NDC
11534019601
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA209799FDA Approved
12/28/2017
TE Code
AB
On Market Since
7/4/2018
Pharmacological Classes
Price Statistics
The NADAC for DEXTROAMP-AMPHETAMIN 30 MG TAB has been published 311 times since Sep 9, 2020, and over the history we have for it it has declined 21.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3031 per EA |
|---|---|
| All-time high | $0.4212 (Dec 16, 2020) |
| All-time low | $0.2416 (Jul 17, 2024) |
| 52-week high | $0.3250 |
| 52-week low | $0.2992 |
| Median price | $0.3159 |
| Average price | $0.3252 |
| Largest weekly change | -26.9% (Nov 20, 2024) |
| Weeks tracked | 311 |
| Tracking since | Sep 9, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DEXTROAMP-AMPHETAMIN 30 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHETAMIN 30 MG TAB, manufactured by Sunrise Pharmaceutical Inc., is $0.3031 per EA (NDC 11534019601), effective Aug 19, 2026.
How has the price of DEXTROAMP-AMPHETAMIN 30 MG TAB changed over time?
Over the history we have for it, the NADAC for DEXTROAMP-AMPHETAMIN 30 MG TAB has declined 21.6%. It has been tracked across 311 weekly CMS publications since Sep 9, 2020.
What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHETAMIN 30 MG TAB?
Since Sep 9, 2020, the NADAC for DEXTROAMP-AMPHETAMIN 30 MG TAB has ranged from a low of $0.2416 (Jul 17, 2024) to a high of $0.4212 (Dec 16, 2020), with a median of $0.3159 per EA.
Are there cheaper alternatives to DEXTROAMP-AMPHETAMIN 30 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of DEXTROAMP-AMPHETAMIN 30 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DEXTROAMP-AMPHETAMIN 30 MG TAB?
DEXTROAMP-AMPHETAMIN 30 MG TAB (NDC 11534019601) is labeled by Sunrise Pharmaceutical Inc., and CMS classifies it as a generic product.
Is DEXTROAMP-AMPHETAMIN 30 MG TAB in shortage?
Yes — NDC 11534019601 is currently listed in FDA's drug shortage database (posted Oct 12, 2022).